Table 2.
Comparison of TEMA and APM for antimycobacterial susceptibility testing of Non-tubercular mycobacterial isolates
| APM | ||||||||||||||
| STR | RIF | ETH | CIP | OFL | ATH | CLA | ||||||||
| TEMA | S | R | S | R | S | R | S | R | S | R | S | R | S | R |
| Sensitive | 43 | 1 | 45 | 0 | 36 | 0 | 50 | 0 | 53 | 0 | 43 | 0 | 45 | 0 |
| Resistant | 1 | 10 | 1 | 9 | 0 | 19 | 0 | 5 | 1 | 1 | 1 | 11 | 1 | 9 |
| Total | 44 | 11 | 46 | 9 | 36 | 19 | 50 | 5 | 54 | 1 | 44 | 11 | 46 | 9 |
| Percentage | (80%) | (20%) | (83.6%) | (16.4%) | (65.5%) | (34.5%) | (91%) | (9%) | (98.2%) | (1.8%) | (80%) | (20%) | (83.6%) | (16.4%) |
| Concordance | 96.4% | 98% | 100% | 100% | 98% | 98% | 98% | |||||||
TEMA: Tetrazolium Microplate Assay, STR: Streptomycin, RIF: Rifampicin, ETH: Ethambutol, CIP: Ciprofloxacin, OFL: Ofloxacin, ATH: Azithromycin, CLA: Clarithromycin, S: Sensitive, R: Resistant.